Blackrock Microsystems

Blackrock Neurotech is a medical device company specializing in brain-computer interface (BCI) technologies for patients with paralysis, ALS, blindness, and other neurological disorders. Founded in 2008, the company has conducted over 19 years of human studies and accumulated more than 30,000 days of implant research. Core technologies include implantable microelectrode arrays (Utah Array) that decode neural signals, enabling users to control computers, robotic arms, and prosthetics through thought alone. The MoveAgain BCI platform is designed for clinical use to enhance patient independence and restore function. Blackrock Neurotech supports over 1,000 research institutions worldwide with neurotechnology devices and research solutions, with documented achievements in neuroprosthetics demonstrating significant improvements in patient quality of life and functional capabilities.